Global Medical Aesthetic Dermal Filler Market Research Report 2022

Medical Aesthetic Filler are injected under the skin to restore lost volume, smooth and soften wrinkles or enhance facial contours. Injectable dermal fillers have developed rapidly and are getting closer and closer to "perfect" products: long-lasting but non-permanent, high tolerability, exquisite and natural cosmetic effects, and reversible in the event of adverse surgical outcomes.
Due to the COVID-19 pandemic, the global Medical Aesthetic Dermal Filler market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Medical Aesthetic Dermal Filler market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Medical Aesthetic Dermal Filler landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Hyaluronic Acid accounting for % of the Medical Aesthetic Dermal Filler global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Medical Aesthetic Dermal Filler include AbbVie, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma, Beijing IMEIK and Bloomage Bio, etc. In terms of revenue, the global 3 largest players have a % market share of Medical Aesthetic Dermal Filler in 2021.
This report focuses on Medical Aesthetic Dermal Filler volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Medical Aesthetic Dermal Filler market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Medical Aesthetic Dermal Filler Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Hyaluronic Acid
Collagen
CaHA
Others
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
HUGEL
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Q.O.Fill (JW Pharmaceutical)
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Matex-Lab
Jingjia Medical
Genoss
Bohus BioTech
Caregen

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports